New gene target could potentially boost effectiveness of cancer immunotherapy
Preclinical studies suggest that silencing TBK1 may help overcome resistance to treatment
Paper(s) cited
Sun Y, et al. "Targeting TBK1 to overcome resistance to cancer immunotherapy." Nature. Online January 12, 2023. DOI: 10.1038/s41586-023-05704-6.